IDEXX Laboratories (IDXX) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

IDEXX Laboratories Revenue Highlights

Latest Revenue (Y)

$4.30B

Latest Revenue (Q)

$1.11B

Main Segment (Y)

Product

Main Geography (Y)

UNITED STATES

IDEXX Laboratories Revenue by Period

IDEXX Laboratories Revenue by Year

Date	Revenue	Change
2025-12-31	$4.30B	10.42%
2024-12-31	$3.90B	6.46%
2023-12-31	$3.66B	8.72%
2022-12-31	$3.37B	4.73%
2021-12-31	$3.22B	18.79%
2020-12-31	$2.71B	12.45%
2019-12-31	$2.41B	8.75%
2018-12-31	$2.21B	12.40%
2017-12-31	$1.97B	10.91%
2016-12-31	$1.78B	10.83%
2015-12-31	$1.60B	7.81%
2014-12-31	$1.49B	7.90%
2013-12-31	$1.38B	6.47%
2012-12-31	$1.29B	6.13%
2011-12-31	$1.22B	10.45%
2010-12-31	$1.10B	6.96%
2009-12-31	$1.03B	0.74%
2008-12-31	$1.02B	11.00%
2007-12-31	$922.55M	24.82%
2006-12-31	$739.12M	15.83%
2005-12-31	$638.10M	16.19%
2004-12-31	$549.18M	15.38%
2003-12-31	$475.99M	15.34%
2002-12-31	$412.67M	6.89%
2001-12-31	$386.08M	5.08%
2000-12-31	$367.43M	3.15%
1999-12-31	$356.20M	11.35%
1998-12-31	$319.90M	21.63%
1997-12-31	$263.00M	-1.76%
1996-12-31	$267.70M	41.94%
1995-12-31	$188.60M	49.21%
1994-12-31	$126.40M	35.77%
1993-12-31	$93.10M	-

IDEXX Laboratories generated $4.30B in revenue during NA 2025, up 10.42% compared to the previous quarter, and up 159.00% compared to the same period a year ago.

IDEXX Laboratories Revenue by Quarter

Date	Revenue	Change
2025-09-30	$1.11B	-0.38%
2025-06-30	$1.11B	11.12%
2025-03-31	$998.43M	4.63%
2024-12-31	$954.29M	-2.18%
2024-09-30	$975.54M	-2.79%
2024-06-30	$1.00B	4.10%
2024-03-31	$964.10M	6.93%
2023-12-31	$901.60M	-1.52%
2023-09-30	$915.53M	-2.98%
2023-06-30	$943.63M	4.83%
2023-03-31	$900.20M	8.64%
2022-12-31	$828.57M	-1.56%
2022-09-30	$841.66M	-2.19%
2022-06-30	$860.55M	2.87%
2022-03-31	$836.55M	4.43%
2021-12-31	$801.09M	-1.15%
2021-09-30	$810.42M	-1.90%
2021-06-30	$826.14M	6.23%
2021-03-31	$777.71M	7.87%
2020-12-31	$720.94M	-0.12%
2020-09-30	$721.79M	13.21%
2020-06-30	$637.59M	1.80%
2020-03-31	$626.34M	3.45%
2019-12-31	$605.45M	0.02%
2019-09-30	$605.30M	-2.39%
2019-06-30	$620.10M	7.65%
2019-03-31	$576.06M	4.85%
2018-12-31	$549.39M	0.72%
2018-09-30	$545.45M	-6.08%
2018-06-30	$580.75M	8.02%
2018-03-31	$537.66M	6.23%
2017-12-31	$506.12M	2.88%
2017-09-30	$491.98M	-3.33%
2017-06-30	$508.94M	10.16%
2017-03-31	$462.02M	4.29%
2016-12-31	$443.00M	-1.18%
2016-09-30	$448.31M	-3.91%
2016-06-30	$466.57M	11.74%
2016-03-31	$417.55M	4.47%
2015-12-31	$399.69M	-1.65%
2015-09-30	$406.39M	-1.68%
2015-06-30	$413.34M	8.07%
2015-03-31	$382.48M	8.67%
2014-12-31	$351.96M	-8.23%
2014-09-30	$383.52M	-1.69%
2014-06-30	$390.12M	8.31%
2014-03-31	$360.20M	1.73%
2013-12-31	$354.07M	4.66%
2013-09-30	$338.30M	-4.05%
2013-06-30	$352.58M	6.17%
2013-03-31	$332.11M	3.93%
2012-12-31	$319.54M	1.29%
2012-09-30	$315.48M	-6.01%
2012-06-30	$335.65M	4.02%
2012-03-31	$322.68M	5.04%
2011-12-31	$307.20M	2.08%
2011-09-30	$300.95M	-5.32%
2011-06-30	$317.86M	8.61%
2011-03-31	$292.67M	3.14%
2010-12-31	$283.76M	5.24%
2010-09-30	$269.63M	-4.21%
2010-06-30	$281.48M	4.83%
2010-03-31	$268.52M	-0.67%
2009-12-31	$270.33M	4.33%
2009-09-30	$259.12M	-2.48%
2009-06-30	$265.72M	12.38%
2009-03-31	$236.46M	-2.81%
2008-12-31	$243.29M	-3.11%
2008-09-30	$251.09M	-10.51%
2008-06-30	$280.57M	12.65%
2008-03-31	$249.07M	1.68%
2007-12-31	$244.97M	-

IDEXX Laboratories generated $1.11B in revenue during Q3 2025, up -0.38% compared to the previous quarter, and up 110.13% compared to the same period a year ago.

IDEXX Laboratories Revenue Breakdown

IDEXX Laboratories Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Service	$1.76B	$1.65B	$1.57B	$1.44B	$1.34B
Product	$2.54B	$2.25B	$2.09B	$1.93B	$1.88B
Instrument Rebate Programs	-	-	-	$12.00M	$14.30M
Reagent Rental Programs	-	-	-	$42.80M	$38.30M
Up Front Customer Loyalty Programs And Volume Commitment Programs	-	-	-	$3.20B	$2.90B
Extended Warranties And Post Contract Support	-	-	-	$11.30M	$16.00M

IDEXX Laboratories's latest annual revenue breakdown by segment (product or service), as of Dec 25: Product (59.00%), and Service (41.00%).

Quarterly Revenue by Product

Product/Service	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20
Product	$652.44M	$656.16M	$657.56M	$573.05M	$1.14B	$567.99M	$543.05M	$1.04B	$540.68M	$505.94M	$476.87M	$481.00M	$492.52M	$478.38M	$468.46M	$471.79M	$480.71M	$454.35M	$433.69M	-
Service	$438.14M	$449.08M	$451.90M	$425.38M	$820.72M	$407.56M	$421.05M	$773.81M	$402.95M	$394.25M	$351.69M	$360.66M	$368.03M	$358.17M	$332.63M	$338.63M	$345.43M	$323.36M	$287.24M	-
Extended Warranties And Post Contract Support	-	-	-	-	-	-	-	-	$9.60M	$1.90M	$11.70M	$14.40M	$2.30M	$17.10M	-	-	-	-	-	-
Instrument Rebate Programs	-	-	-	-	-	-	-	-	$2.20M	$2.70M	$2.90M	$3.40M	$3.30M	$3.50M	-	-	-	-	-	-
Reagent Rental Programs	-	-	-	-	-	-	-	-	$51.00M	$35.90M	$37.20M	$39.10M	-	-	-	-	-	-	-	-
Up Front Customer Loyalty Programs And Volume Commitment Programs	-	-	-	-	-	-	-	-	$2.90B	$3.00B	$3.00B	$2.70B	-	-	-	-	-	-	-	-

IDEXX Laboratories's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Product (59.83%), and Service (40.17%).

IDEXX Laboratories Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
CANADA	$167.32M	$152.88M	$150.11M	$142.74M	-
EMEA	$937.25M	$806.73M	$716.18M	-	-
Europe, the Middle East, and Africa, Other	$230.03M	$196.31M	$176.40M	-	-
Asia Pacific	$355.93M	$321.02M	$423.42M	-	-
Latin America	$90.41M	$83.69M	$83.92M	-	-
UNITED STATES	$2.75B	$2.53B	$2.49B	-	-
NETHERLANDS	-	$34.05M	$30.51M	-	-
SPAIN	-	$61.86M	$52.33M	-	-
SWITZERLAND	-	$37.18M	$34.83M	$30.65M	$31.98M
UNITED KINGDOM	-	$134.63M	$121.75M	-	-
FRANCE	-	$110.80M	$96.80M	-	-
GERMANY	-	$173.68M	$149.79M	-	-
ITALY	-	$58.22M	$53.79M	-	-
JAPAN	-	$73.14M	$75.57M	-	-
Americas	-	$2.77B	$2.63B	-	-
CHINA	-	$35.82M	$44.17M	-	-
Asia Pacific Region, Other	-	-	$104.11M	-	-
AUSTRALIA	-	-	$95.47M	-	-
Latin America and Caribbean	-	-	$83.92M	-	-

IDEXX Laboratories's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (60.72%), EMEA (20.67%), Asia Pacific (7.85%), Europe, the Middle East, and Africa, Other (5.07%), CANADA (3.69%), and Latin America (1.99%).

Quarterly Revenue by Country

Country	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20
UNITED STATES	$675.01M	$705.04M	$717.87M	$654.86M	$1.37B	$638.06M	$631.01M	$671.83M	$603.05M	$559.83M	$525.91M	$493.46M	$514.34M	$515.24M	$472.64M	$433.61M	-	-	-	-
Latin America	$45.05M	$23.04M	$22.33M	$42.47M	$20.98M	$20.24M	$22.30M	$17.07M	$16.39M	$15.58M	$15.67M	-	-	-	-	-	-	-	-	-
EMEA	$254.37M	$245.06M	$233.27M	$204.55M	$408.30M	$198.60M	$199.83M	$183.66M	$177.85M	$161.99M	$173.81M	$171.19M	$167.96M	$171.55M	$171.25M	$161.84M	-	-	-	-
CANADA	$41.96M	$41.38M	$46.69M	$37.30M	$79.25M	$36.93M	$36.71M	$36.90M	$35.61M	$41.63M	$35.96M	$34.34M	$33.64M	$39.53M	$35.23M	$34.12M	$32.81M	$39.34M	$33.46M	$29.08M
Asia Pacific	$94.17M	$90.72M	$89.30M	$81.73M	$163.75M	$80.97M	$76.30M	$186.48M	$77.67M	$80.10M	$83.86M	$84.73M	$78.24M	$83.62M	$84.78M	$80.74M	-	-	-	-
Latin American and Caribbean	-	-	-	-	-	-	-	-	$21.35M	$19.09M	$17.74M	-	-	-	-	-	-	-	-	-

IDEXX Laboratories's latest quarterly revenue breakdown by geography, as of Dec 25: UNITED STATES (60.78%), EMEA (22.90%), Asia Pacific (8.48%), Latin America (4.06%), and CANADA (3.78%).

IDEXX Laboratories Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
COR	Cencora	$321.33B	$85.93B
CAH	Cardinal Health	$222.58B	$65.44B
BDX	Becton, Dickinson and	$21.84B	$5.25B
IQV	IQVIA	$16.31B	$4.10B
ZTS	Zoetis	$9.47B	$2.40B
A	Agilent	$6.83B	$1.80B
EW	Edwards Lifesciences	$6.07B	$1.55B
IDXX	IDEXX Laboratories	$4.30B	$1.11B
ALNY	Alnylam Pharmaceuticals	$3.71B	$1.25B
VEEV	Veeva Systems	$2.75B	$811.24M
ARGX	argenx SE	$1.23B	$401.00M

IDXX Revenue FAQ

What is IDEXX Laboratories’s yearly revenue?

IDEXX Laboratories's yearly revenue for 2025 was $4.3B, representing an increase of 10.42% compared to 2024. The company's yearly revenue for 2024 was $3.9B, representing an increase of 6.46% compared to 2023. IDXX's yearly revenue for 2023 was $3.66B, representing an increase of 8.72% compared to 2022.

What is IDEXX Laboratories’s quarterly revenue?

IDEXX Laboratories's quarterly revenue for Q3 2025 was $1.11B, a -0.38% decrease from the previous quarter (Q2 2025), and a 13.29% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $1.11B, a 11.12% increase from the previous quarter (Q1 2025), and a 10.55% increase year-over-year (Q2 2024). IDXX's quarterly revenue for Q1 2025 was $998.43M, a 4.63% increase from the previous quarter (Q4 2024), and a 3.56% increase year-over-year (Q1 2024).

What is IDEXX Laboratories’s revenue growth rate?

IDEXX Laboratories's revenue growth rate for the last 3 years (2023-2025) was 17.56%, and for the last 5 years (2021-2025) was 33.85%.

What are IDEXX Laboratories’s revenue streams?

IDEXX Laboratories's revenue streams in c 25 are Service, and Product. Service generated $1.76B in revenue, accounting 41.00% of the company's total revenue, up 6.98% year-over-year. Product generated $2.54B in revenue, accounting 59.00% of the company's total revenue, up 12.95% year-over-year.

What is IDEXX Laboratories’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of IDEXX Laboratories was Product. This segment made a revenue of $2.54B, representing 59.00% of the company's total revenue.